Photo Credit: Paul Biris
The following is a summary of “Characteristics and outcomes in bladder Leiomyoma management: a systematic review of case reports and case series from the past 20 years,” published in the November 2024 issue of Urology by Prihadi et al.
Bladder leiomyomas are rare, benign tumors from bladder smooth muscle, comprising 0.5% of bladder tumors.
Researchers conducted a retrospective study to summarize bladder leiomyomas’ characteristics, management, and outcomes.
They conducted a systematic review using four databases—PubMed, Proquest, EBSCOHost, and Google Scholar—until January 2024. They included case studies or series on surgical outcomes for bladder leiomyoma and used MeSH terms like “leiomyoma” and “urinary bladder,” along with synonyms.
The results showed 99 studies with 119 patients, 79.0% female. Most presented with LUTS (59.7%) or hematuria (24.4%), while 16.8% were incidental findings. CT, MRI, USG, and cystoscopy were common diagnostics. Tumors were often on the left lateral wall (26.9%) or bladder neck (17.6%). Over half (52.1%) underwent TURBt/TUR. Recurrence or persistent symptoms occurred in 12.6%, linked to initial symptoms and extended tumor location.
They emphasized symptom relief and recurrence prevention, tailoring management to individual cases. They suggested further research with larger trials to refine treatment strategies and long-term outcomes.
Source: bmcurol.biomedcentral.com/articles/10.1186/s12894-024-01624-3
